nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CYP2B6—Ifosfamide—testicular cancer	0.184	0.235	CbGbCtD
Prasugrel—CYP2C19—Ifosfamide—testicular cancer	0.117	0.149	CbGbCtD
Prasugrel—CYP2C9—Ifosfamide—testicular cancer	0.097	0.124	CbGbCtD
Prasugrel—CYP2B6—Cisplatin—testicular cancer	0.0893	0.114	CbGbCtD
Prasugrel—CYP2B6—Doxorubicin—testicular cancer	0.0599	0.0765	CbGbCtD
Prasugrel—ALB—Methotrexate—testicular cancer	0.0568	0.0727	CbGbCtD
Prasugrel—CYP3A4—Ifosfamide—testicular cancer	0.0564	0.0721	CbGbCtD
Prasugrel—CYP2C9—Cisplatin—testicular cancer	0.0472	0.0603	CbGbCtD
Prasugrel—CYP3A4—Vinblastine—testicular cancer	0.0299	0.0383	CbGbCtD
Prasugrel—CYP3A4—Etoposide—testicular cancer	0.027	0.0345	CbGbCtD
Prasugrel—CYP3A4—Doxorubicin—testicular cancer	0.0184	0.0235	CbGbCtD
Prasugrel—Cerebrovascular accident—Cisplatin—testicular cancer	0.00147	0.00674	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Cisplatin—testicular cancer	0.00144	0.00661	CcSEcCtD
Prasugrel—Haematuria—Bleomycin—testicular cancer	0.00144	0.00659	CcSEcCtD
Prasugrel—Hyperlipidaemia—Epirubicin—testicular cancer	0.00141	0.00649	CcSEcCtD
Prasugrel—Anaemia—Chlorambucil—testicular cancer	0.00141	0.00645	CcSEcCtD
Prasugrel—Angioedema—Chlorambucil—testicular cancer	0.00139	0.00638	CcSEcCtD
Prasugrel—Haemoptysis—Epirubicin—testicular cancer	0.00138	0.00632	CcSEcCtD
Prasugrel—Leukopenia—Chlorambucil—testicular cancer	0.00136	0.00625	CcSEcCtD
Prasugrel—Haemoglobin—Bleomycin—testicular cancer	0.00136	0.00624	CcSEcCtD
Prasugrel—Haemorrhage—Bleomycin—testicular cancer	0.00135	0.0062	CcSEcCtD
Prasugrel—Hyperlipidaemia—Doxorubicin—testicular cancer	0.00131	0.006	CcSEcCtD
Prasugrel—Anaemia—Vinblastine—testicular cancer	0.00129	0.00591	CcSEcCtD
Prasugrel—Haemoptysis—Doxorubicin—testicular cancer	0.00127	0.00584	CcSEcCtD
Prasugrel—Leukopenia—Vinblastine—testicular cancer	0.00125	0.00572	CcSEcCtD
Prasugrel—Haematuria—Ifosfamide—testicular cancer	0.00123	0.00563	CcSEcCtD
Prasugrel—Thrombocytopenia—Chlorambucil—testicular cancer	0.00121	0.00558	CcSEcCtD
Prasugrel—Hypertension—Vinblastine—testicular cancer	0.0012	0.00552	CcSEcCtD
Prasugrel—Neoplasm malignant—Epirubicin—testicular cancer	0.00119	0.00547	CcSEcCtD
Prasugrel—Bradycardia—Ifosfamide—testicular cancer	0.00118	0.0054	CcSEcCtD
Prasugrel—Haemoglobin—Ifosfamide—testicular cancer	0.00116	0.00533	CcSEcCtD
Prasugrel—Haemorrhage—Ifosfamide—testicular cancer	0.00116	0.0053	CcSEcCtD
Prasugrel—Urinary tract disorder—Ifosfamide—testicular cancer	0.00114	0.00524	CcSEcCtD
Prasugrel—Urethral disorder—Ifosfamide—testicular cancer	0.00113	0.0052	CcSEcCtD
Prasugrel—Rectal haemorrhage—Epirubicin—testicular cancer	0.00113	0.00518	CcSEcCtD
Prasugrel—Thrombocytopenia—Vinblastine—testicular cancer	0.00111	0.00511	CcSEcCtD
Prasugrel—Neoplasm malignant—Doxorubicin—testicular cancer	0.0011	0.00507	CcSEcCtD
Prasugrel—Anaemia—Bleomycin—testicular cancer	0.00109	0.00499	CcSEcCtD
Prasugrel—Eye disorder—Ifosfamide—testicular cancer	0.00108	0.00496	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00107	0.00492	CcSEcCtD
Prasugrel—Fatigue—Chlorambucil—testicular cancer	0.00107	0.00491	CcSEcCtD
Prasugrel—Leukopenia—Bleomycin—testicular cancer	0.00105	0.00483	CcSEcCtD
Prasugrel—Angiopathy—Ifosfamide—testicular cancer	0.00105	0.00481	CcSEcCtD
Prasugrel—Immune system disorder—Ifosfamide—testicular cancer	0.00104	0.00479	CcSEcCtD
Prasugrel—Rectal haemorrhage—Doxorubicin—testicular cancer	0.00104	0.00479	CcSEcCtD
Prasugrel—Mediastinal disorder—Ifosfamide—testicular cancer	0.00104	0.00478	CcSEcCtD
Prasugrel—Cough—Bleomycin—testicular cancer	0.00103	0.00471	CcSEcCtD
Prasugrel—Anaemia—Dactinomycin—testicular cancer	0.00101	0.00466	CcSEcCtD
Prasugrel—Bradycardia—Cisplatin—testicular cancer	0.00101	0.00465	CcSEcCtD
Prasugrel—Ecchymosis—Methotrexate—testicular cancer	0.000984	0.00452	CcSEcCtD
Prasugrel—Neoplasm—Methotrexate—testicular cancer	0.000984	0.00452	CcSEcCtD
Prasugrel—Urinary tract disorder—Cisplatin—testicular cancer	0.000983	0.00451	CcSEcCtD
Prasugrel—Leukopenia—Dactinomycin—testicular cancer	0.000982	0.00451	CcSEcCtD
Prasugrel—Body temperature increased—Chlorambucil—testicular cancer	0.000981	0.0045	CcSEcCtD
Prasugrel—Urethral disorder—Cisplatin—testicular cancer	0.000976	0.00448	CcSEcCtD
Prasugrel—Anaphylactic shock—Bleomycin—testicular cancer	0.00096	0.00441	CcSEcCtD
Prasugrel—Thrombocytopenia—Bleomycin—testicular cancer	0.00094	0.00432	CcSEcCtD
Prasugrel—Eye disorder—Cisplatin—testicular cancer	0.000931	0.00427	CcSEcCtD
Prasugrel—Anaemia—Ifosfamide—testicular cancer	0.000929	0.00427	CcSEcCtD
Prasugrel—Ecchymosis—Epirubicin—testicular cancer	0.000921	0.00423	CcSEcCtD
Prasugrel—Neoplasm—Epirubicin—testicular cancer	0.000921	0.00423	CcSEcCtD
Prasugrel—Angioedema—Ifosfamide—testicular cancer	0.000919	0.00422	CcSEcCtD
Prasugrel—Hypersensitivity—Chlorambucil—testicular cancer	0.000914	0.0042	CcSEcCtD
Prasugrel—Urinary tract disorder—Etoposide—testicular cancer	0.000901	0.00414	CcSEcCtD
Prasugrel—Leukopenia—Ifosfamide—testicular cancer	0.0009	0.00413	CcSEcCtD
Prasugrel—Immune system disorder—Cisplatin—testicular cancer	0.000899	0.00413	CcSEcCtD
Prasugrel—Mediastinal disorder—Cisplatin—testicular cancer	0.000897	0.00412	CcSEcCtD
Prasugrel—Hypotension—Bleomycin—testicular cancer	0.000897	0.00412	CcSEcCtD
Prasugrel—Urethral disorder—Etoposide—testicular cancer	0.000894	0.00411	CcSEcCtD
Prasugrel—Asthenia—Chlorambucil—testicular cancer	0.00089	0.00409	CcSEcCtD
Prasugrel—Cough—Ifosfamide—testicular cancer	0.000877	0.00403	CcSEcCtD
Prasugrel—Thrombocytopenia—Dactinomycin—testicular cancer	0.000877	0.00403	CcSEcCtD
Prasugrel—Hypertension—Ifosfamide—testicular cancer	0.000868	0.00399	CcSEcCtD
Prasugrel—Dyspnoea—Bleomycin—testicular cancer	0.000856	0.00393	CcSEcCtD
Prasugrel—Eye disorder—Etoposide—testicular cancer	0.000853	0.00391	CcSEcCtD
Prasugrel—Ecchymosis—Doxorubicin—testicular cancer	0.000852	0.00391	CcSEcCtD
Prasugrel—Neoplasm—Doxorubicin—testicular cancer	0.000852	0.00391	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00085	0.0039	CcSEcCtD
Prasugrel—Diarrhoea—Chlorambucil—testicular cancer	0.000849	0.0039	CcSEcCtD
Prasugrel—Hypersensitivity—Vinblastine—testicular cancer	0.000838	0.00385	CcSEcCtD
Prasugrel—Angiopathy—Etoposide—testicular cancer	0.000828	0.0038	CcSEcCtD
Prasugrel—Immune system disorder—Etoposide—testicular cancer	0.000824	0.00378	CcSEcCtD
Prasugrel—Mediastinal disorder—Etoposide—testicular cancer	0.000822	0.00377	CcSEcCtD
Prasugrel—Anaphylactic shock—Ifosfamide—testicular cancer	0.000821	0.00377	CcSEcCtD
Prasugrel—Asthenia—Vinblastine—testicular cancer	0.000816	0.00374	CcSEcCtD
Prasugrel—Cerebrovascular accident—Methotrexate—testicular cancer	0.000806	0.0037	CcSEcCtD
Prasugrel—Thrombocytopenia—Ifosfamide—testicular cancer	0.000804	0.00369	CcSEcCtD
Prasugrel—Anaemia—Cisplatin—testicular cancer	0.000801	0.00368	CcSEcCtD
Prasugrel—Skin disorder—Ifosfamide—testicular cancer	0.000797	0.00366	CcSEcCtD
Prasugrel—Diarrhoea—Vinblastine—testicular cancer	0.000778	0.00357	CcSEcCtD
Prasugrel—Leukopenia—Cisplatin—testicular cancer	0.000776	0.00356	CcSEcCtD
Prasugrel—Fatigue—Dactinomycin—testicular cancer	0.000772	0.00354	CcSEcCtD
Prasugrel—Back pain—Etoposide—testicular cancer	0.000768	0.00353	CcSEcCtD
Prasugrel—Hypotension—Ifosfamide—testicular cancer	0.000767	0.00352	CcSEcCtD
Prasugrel—Body temperature increased—Bleomycin—testicular cancer	0.000759	0.00348	CcSEcCtD
Prasugrel—Cerebrovascular accident—Epirubicin—testicular cancer	0.000754	0.00346	CcSEcCtD
Prasugrel—Dizziness—Vinblastine—testicular cancer	0.000752	0.00345	CcSEcCtD
Prasugrel—Pain in extremity—Epirubicin—testicular cancer	0.000739	0.00339	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.000739	0.00339	CcSEcCtD
Prasugrel—Nausea—Chlorambucil—testicular cancer	0.000737	0.00338	CcSEcCtD
Prasugrel—Anaemia—Etoposide—testicular cancer	0.000734	0.00337	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000733	0.00336	CcSEcCtD
Prasugrel—Dyspnoea—Ifosfamide—testicular cancer	0.000732	0.00336	CcSEcCtD
Prasugrel—Headache—Vinblastine—testicular cancer	0.000712	0.00327	CcSEcCtD
Prasugrel—Leukopenia—Etoposide—testicular cancer	0.000711	0.00326	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000709	0.00325	CcSEcCtD
Prasugrel—Body temperature increased—Dactinomycin—testicular cancer	0.000708	0.00325	CcSEcCtD
Prasugrel—Fatigue—Ifosfamide—testicular cancer	0.000708	0.00325	CcSEcCtD
Prasugrel—Anaphylactic shock—Cisplatin—testicular cancer	0.000708	0.00325	CcSEcCtD
Prasugrel—Hypersensitivity—Bleomycin—testicular cancer	0.000707	0.00325	CcSEcCtD
Prasugrel—Cerebrovascular accident—Doxorubicin—testicular cancer	0.000698	0.0032	CcSEcCtD
Prasugrel—Cough—Etoposide—testicular cancer	0.000693	0.00318	CcSEcCtD
Prasugrel—Thrombocytopenia—Cisplatin—testicular cancer	0.000693	0.00318	CcSEcCtD
Prasugrel—Asthenia—Bleomycin—testicular cancer	0.000689	0.00316	CcSEcCtD
Prasugrel—Skin disorder—Cisplatin—testicular cancer	0.000687	0.00315	CcSEcCtD
Prasugrel—Hypertension—Etoposide—testicular cancer	0.000686	0.00315	CcSEcCtD
Prasugrel—Pain in extremity—Doxorubicin—testicular cancer	0.000684	0.00314	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.000684	0.00314	CcSEcCtD
Prasugrel—Nausea—Vinblastine—testicular cancer	0.000675	0.0031	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000671	0.00308	CcSEcCtD
Prasugrel—Hypotension—Cisplatin—testicular cancer	0.000661	0.00303	CcSEcCtD
Prasugrel—Hypersensitivity—Dactinomycin—testicular cancer	0.00066	0.00303	CcSEcCtD
Prasugrel—Body temperature increased—Ifosfamide—testicular cancer	0.000649	0.00298	CcSEcCtD
Prasugrel—Anaphylactic shock—Etoposide—testicular cancer	0.000648	0.00298	CcSEcCtD
Prasugrel—Asthenia—Dactinomycin—testicular cancer	0.000643	0.00295	CcSEcCtD
Prasugrel—Thrombocytopenia—Etoposide—testicular cancer	0.000635	0.00291	CcSEcCtD
Prasugrel—Dyspnoea—Cisplatin—testicular cancer	0.000631	0.0029	CcSEcCtD
Prasugrel—Skin disorder—Etoposide—testicular cancer	0.00063	0.00289	CcSEcCtD
Prasugrel—Diarrhoea—Dactinomycin—testicular cancer	0.000613	0.00281	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000611	0.0028	CcSEcCtD
Prasugrel—Hypotension—Etoposide—testicular cancer	0.000606	0.00278	CcSEcCtD
Prasugrel—Rash—Bleomycin—testicular cancer	0.000605	0.00278	CcSEcCtD
Prasugrel—Dermatitis—Bleomycin—testicular cancer	0.000605	0.00278	CcSEcCtD
Prasugrel—Hypersensitivity—Ifosfamide—testicular cancer	0.000605	0.00278	CcSEcCtD
Prasugrel—Asthenia—Ifosfamide—testicular cancer	0.000589	0.0027	CcSEcCtD
Prasugrel—Haematuria—Methotrexate—testicular cancer	0.00058	0.00266	CcSEcCtD
Prasugrel—Dyspnoea—Etoposide—testicular cancer	0.000578	0.00265	CcSEcCtD
Prasugrel—Epistaxis—Methotrexate—testicular cancer	0.000574	0.00264	CcSEcCtD
Prasugrel—Nausea—Bleomycin—testicular cancer	0.00057	0.00262	CcSEcCtD
Prasugrel—Rash—Dactinomycin—testicular cancer	0.000565	0.00259	CcSEcCtD
Prasugrel—Diarrhoea—Ifosfamide—testicular cancer	0.000562	0.00258	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Etoposide—testicular cancer	0.00056	0.00257	CcSEcCtD
Prasugrel—Body temperature increased—Cisplatin—testicular cancer	0.000559	0.00257	CcSEcCtD
Prasugrel—Fatigue—Etoposide—testicular cancer	0.000559	0.00257	CcSEcCtD
Prasugrel—Haemoglobin—Methotrexate—testicular cancer	0.000549	0.00252	CcSEcCtD
Prasugrel—Haemorrhage—Methotrexate—testicular cancer	0.000546	0.00251	CcSEcCtD
Prasugrel—Haematuria—Epirubicin—testicular cancer	0.000543	0.00249	CcSEcCtD
Prasugrel—Dizziness—Ifosfamide—testicular cancer	0.000543	0.00249	CcSEcCtD
Prasugrel—Urinary tract disorder—Methotrexate—testicular cancer	0.00054	0.00248	CcSEcCtD
Prasugrel—Epistaxis—Epirubicin—testicular cancer	0.000537	0.00247	CcSEcCtD
Prasugrel—Urethral disorder—Methotrexate—testicular cancer	0.000536	0.00246	CcSEcCtD
Prasugrel—Nausea—Dactinomycin—testicular cancer	0.000532	0.00244	CcSEcCtD
Prasugrel—Hypersensitivity—Cisplatin—testicular cancer	0.000521	0.00239	CcSEcCtD
Prasugrel—Bradycardia—Epirubicin—testicular cancer	0.000521	0.00239	CcSEcCtD
Prasugrel—Rash—Ifosfamide—testicular cancer	0.000517	0.00238	CcSEcCtD
Prasugrel—Dermatitis—Ifosfamide—testicular cancer	0.000517	0.00237	CcSEcCtD
Prasugrel—Haemoglobin—Epirubicin—testicular cancer	0.000514	0.00236	CcSEcCtD
Prasugrel—Body temperature increased—Etoposide—testicular cancer	0.000512	0.00235	CcSEcCtD
Prasugrel—Haemorrhage—Epirubicin—testicular cancer	0.000511	0.00235	CcSEcCtD
Prasugrel—Eye disorder—Methotrexate—testicular cancer	0.000511	0.00234	CcSEcCtD
Prasugrel—Asthenia—Cisplatin—testicular cancer	0.000508	0.00233	CcSEcCtD
Prasugrel—Urinary tract disorder—Epirubicin—testicular cancer	0.000505	0.00232	CcSEcCtD
Prasugrel—Oedema peripheral—Epirubicin—testicular cancer	0.000504	0.00231	CcSEcCtD
Prasugrel—Haematuria—Doxorubicin—testicular cancer	0.000503	0.00231	CcSEcCtD
Prasugrel—Urethral disorder—Epirubicin—testicular cancer	0.000501	0.0023	CcSEcCtD
Prasugrel—Epistaxis—Doxorubicin—testicular cancer	0.000497	0.00228	CcSEcCtD
Prasugrel—Angiopathy—Methotrexate—testicular cancer	0.000496	0.00228	CcSEcCtD
Prasugrel—Immune system disorder—Methotrexate—testicular cancer	0.000494	0.00227	CcSEcCtD
Prasugrel—Mediastinal disorder—Methotrexate—testicular cancer	0.000492	0.00226	CcSEcCtD
Prasugrel—Nausea—Ifosfamide—testicular cancer	0.000487	0.00224	CcSEcCtD
Prasugrel—Diarrhoea—Cisplatin—testicular cancer	0.000484	0.00222	CcSEcCtD
Prasugrel—Bradycardia—Doxorubicin—testicular cancer	0.000482	0.00221	CcSEcCtD
Prasugrel—Eye disorder—Epirubicin—testicular cancer	0.000478	0.00219	CcSEcCtD
Prasugrel—Hypersensitivity—Etoposide—testicular cancer	0.000478	0.00219	CcSEcCtD
Prasugrel—Haemoglobin—Doxorubicin—testicular cancer	0.000476	0.00218	CcSEcCtD
Prasugrel—Haemorrhage—Doxorubicin—testicular cancer	0.000473	0.00217	CcSEcCtD
Prasugrel—Urinary tract disorder—Doxorubicin—testicular cancer	0.000467	0.00215	CcSEcCtD
Prasugrel—Oedema peripheral—Doxorubicin—testicular cancer	0.000466	0.00214	CcSEcCtD
Prasugrel—Asthenia—Etoposide—testicular cancer	0.000465	0.00213	CcSEcCtD
Prasugrel—Angiopathy—Epirubicin—testicular cancer	0.000464	0.00213	CcSEcCtD
Prasugrel—Urethral disorder—Doxorubicin—testicular cancer	0.000464	0.00213	CcSEcCtD
Prasugrel—Immune system disorder—Epirubicin—testicular cancer	0.000462	0.00212	CcSEcCtD
Prasugrel—Mediastinal disorder—Epirubicin—testicular cancer	0.000461	0.00212	CcSEcCtD
Prasugrel—Back pain—Methotrexate—testicular cancer	0.00046	0.00211	CcSEcCtD
Prasugrel—Rash—Cisplatin—testicular cancer	0.000446	0.00205	CcSEcCtD
Prasugrel—Dermatitis—Cisplatin—testicular cancer	0.000446	0.00205	CcSEcCtD
Prasugrel—Diarrhoea—Etoposide—testicular cancer	0.000443	0.00204	CcSEcCtD
Prasugrel—Eye disorder—Doxorubicin—testicular cancer	0.000442	0.00203	CcSEcCtD
Prasugrel—Anaemia—Methotrexate—testicular cancer	0.00044	0.00202	CcSEcCtD
Prasugrel—Back pain—Epirubicin—testicular cancer	0.000431	0.00198	CcSEcCtD
Prasugrel—Angiopathy—Doxorubicin—testicular cancer	0.000429	0.00197	CcSEcCtD
Prasugrel—Dizziness—Etoposide—testicular cancer	0.000429	0.00197	CcSEcCtD
Prasugrel—Immune system disorder—Doxorubicin—testicular cancer	0.000427	0.00196	CcSEcCtD
Prasugrel—Mediastinal disorder—Doxorubicin—testicular cancer	0.000426	0.00196	CcSEcCtD
Prasugrel—Leukopenia—Methotrexate—testicular cancer	0.000426	0.00195	CcSEcCtD
Prasugrel—Nausea—Cisplatin—testicular cancer	0.00042	0.00193	CcSEcCtD
Prasugrel—Cough—Methotrexate—testicular cancer	0.000415	0.00191	CcSEcCtD
Prasugrel—Anaemia—Epirubicin—testicular cancer	0.000411	0.00189	CcSEcCtD
Prasugrel—Rash—Etoposide—testicular cancer	0.000409	0.00188	CcSEcCtD
Prasugrel—Dermatitis—Etoposide—testicular cancer	0.000408	0.00187	CcSEcCtD
Prasugrel—Headache—Etoposide—testicular cancer	0.000406	0.00186	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000402	0.00185	CcSEcCtD
Prasugrel—Leukopenia—Epirubicin—testicular cancer	0.000398	0.00183	CcSEcCtD
Prasugrel—Back pain—Doxorubicin—testicular cancer	0.000398	0.00183	CcSEcCtD
Prasugrel—Cough—Epirubicin—testicular cancer	0.000388	0.00178	CcSEcCtD
Prasugrel—Anaphylactic shock—Methotrexate—testicular cancer	0.000388	0.00178	CcSEcCtD
Prasugrel—Nausea—Etoposide—testicular cancer	0.000385	0.00177	CcSEcCtD
Prasugrel—Hypertension—Epirubicin—testicular cancer	0.000384	0.00176	CcSEcCtD
Prasugrel—Anaemia—Doxorubicin—testicular cancer	0.000381	0.00175	CcSEcCtD
Prasugrel—Thrombocytopenia—Methotrexate—testicular cancer	0.00038	0.00175	CcSEcCtD
Prasugrel—Skin disorder—Methotrexate—testicular cancer	0.000377	0.00173	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000376	0.00173	CcSEcCtD
Prasugrel—Leukopenia—Doxorubicin—testicular cancer	0.000369	0.00169	CcSEcCtD
Prasugrel—Anaphylactic shock—Epirubicin—testicular cancer	0.000363	0.00167	CcSEcCtD
Prasugrel—Hypotension—Methotrexate—testicular cancer	0.000363	0.00167	CcSEcCtD
Prasugrel—Cough—Doxorubicin—testicular cancer	0.000359	0.00165	CcSEcCtD
Prasugrel—Thrombocytopenia—Epirubicin—testicular cancer	0.000356	0.00163	CcSEcCtD
Prasugrel—Hypertension—Doxorubicin—testicular cancer	0.000356	0.00163	CcSEcCtD
Prasugrel—Skin disorder—Epirubicin—testicular cancer	0.000353	0.00162	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000348	0.0016	CcSEcCtD
Prasugrel—Dyspnoea—Methotrexate—testicular cancer	0.000346	0.00159	CcSEcCtD
Prasugrel—Hypotension—Epirubicin—testicular cancer	0.00034	0.00156	CcSEcCtD
Prasugrel—Anaphylactic shock—Doxorubicin—testicular cancer	0.000336	0.00154	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000335	0.00154	CcSEcCtD
Prasugrel—Fatigue—Methotrexate—testicular cancer	0.000335	0.00154	CcSEcCtD
Prasugrel—Thrombocytopenia—Doxorubicin—testicular cancer	0.000329	0.00151	CcSEcCtD
Prasugrel—Skin disorder—Doxorubicin—testicular cancer	0.000327	0.0015	CcSEcCtD
Prasugrel—Dyspnoea—Epirubicin—testicular cancer	0.000324	0.00149	CcSEcCtD
Prasugrel—Hypotension—Doxorubicin—testicular cancer	0.000314	0.00144	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000314	0.00144	CcSEcCtD
Prasugrel—Fatigue—Epirubicin—testicular cancer	0.000313	0.00144	CcSEcCtD
Prasugrel—Body temperature increased—Methotrexate—testicular cancer	0.000307	0.00141	CcSEcCtD
Prasugrel—Dyspnoea—Doxorubicin—testicular cancer	0.0003	0.00138	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00029	0.00133	CcSEcCtD
Prasugrel—Fatigue—Doxorubicin—testicular cancer	0.00029	0.00133	CcSEcCtD
Prasugrel—Body temperature increased—Epirubicin—testicular cancer	0.000287	0.00132	CcSEcCtD
Prasugrel—Hypersensitivity—Methotrexate—testicular cancer	0.000286	0.00131	CcSEcCtD
Prasugrel—Asthenia—Methotrexate—testicular cancer	0.000279	0.00128	CcSEcCtD
Prasugrel—Hypersensitivity—Epirubicin—testicular cancer	0.000268	0.00123	CcSEcCtD
Prasugrel—Body temperature increased—Doxorubicin—testicular cancer	0.000266	0.00122	CcSEcCtD
Prasugrel—Diarrhoea—Methotrexate—testicular cancer	0.000266	0.00122	CcSEcCtD
Prasugrel—Asthenia—Epirubicin—testicular cancer	0.000261	0.0012	CcSEcCtD
Prasugrel—Dizziness—Methotrexate—testicular cancer	0.000257	0.00118	CcSEcCtD
Prasugrel—Diarrhoea—Epirubicin—testicular cancer	0.000249	0.00114	CcSEcCtD
Prasugrel—Hypersensitivity—Doxorubicin—testicular cancer	0.000248	0.00114	CcSEcCtD
Prasugrel—Rash—Methotrexate—testicular cancer	0.000245	0.00112	CcSEcCtD
Prasugrel—Dermatitis—Methotrexate—testicular cancer	0.000245	0.00112	CcSEcCtD
Prasugrel—Headache—Methotrexate—testicular cancer	0.000243	0.00112	CcSEcCtD
Prasugrel—Asthenia—Doxorubicin—testicular cancer	0.000241	0.00111	CcSEcCtD
Prasugrel—Dizziness—Epirubicin—testicular cancer	0.00024	0.0011	CcSEcCtD
Prasugrel—Nausea—Methotrexate—testicular cancer	0.000231	0.00106	CcSEcCtD
Prasugrel—Diarrhoea—Doxorubicin—testicular cancer	0.00023	0.00106	CcSEcCtD
Prasugrel—Rash—Epirubicin—testicular cancer	0.000229	0.00105	CcSEcCtD
Prasugrel—Dermatitis—Epirubicin—testicular cancer	0.000229	0.00105	CcSEcCtD
Prasugrel—Headache—Epirubicin—testicular cancer	0.000228	0.00104	CcSEcCtD
Prasugrel—Dizziness—Doxorubicin—testicular cancer	0.000222	0.00102	CcSEcCtD
Prasugrel—Nausea—Epirubicin—testicular cancer	0.000216	0.000991	CcSEcCtD
Prasugrel—Rash—Doxorubicin—testicular cancer	0.000212	0.000973	CcSEcCtD
Prasugrel—Dermatitis—Doxorubicin—testicular cancer	0.000212	0.000972	CcSEcCtD
Prasugrel—Headache—Doxorubicin—testicular cancer	0.000211	0.000967	CcSEcCtD
Prasugrel—Nausea—Doxorubicin—testicular cancer	0.0002	0.000917	CcSEcCtD
